Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Idelalisib in clinical trials
| Study agents | Other agents | Disease | Dosage | Clinical trials | No. Pts. | Response | Reference |
|---|---|---|---|---|---|---|---|
| Idelalisib |
|
Relapsed |
150 mg |
Phase I |
54 |
ORR:26% |
[44,45] |
| Refractory | |||||||
| Idelalisib |
Rituximab |
Relapsed |
150 mg |
Phase I |
51 |
ORR:74/82/87% |
[46] |
| Bendamustine | Refractory | 1 year PFS:74/88/87% |
Abbreviations: ORR overall response rate, PFS progression-free survival.
